WO2012148148A3 - Novel zinc azide complex and a process for preparing tetrazole derivatives using the same - Google Patents
Novel zinc azide complex and a process for preparing tetrazole derivatives using the same Download PDFInfo
- Publication number
- WO2012148148A3 WO2012148148A3 PCT/KR2012/003135 KR2012003135W WO2012148148A3 WO 2012148148 A3 WO2012148148 A3 WO 2012148148A3 KR 2012003135 W KR2012003135 W KR 2012003135W WO 2012148148 A3 WO2012148148 A3 WO 2012148148A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- same
- zinc azide
- tetrazole derivatives
- azide complex
- novel zinc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/06—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Abstract
The present invention relates to a novel zinc azide complex. The present invention also relates to a process for preparing 5-substituted-1H-tetrazole derivatives from nitrile derivatives by using the zinc azide complex. According to the present invention, in particular, pharmaceutically active compounds for treating hypertension or intermediates useful for preparation thereof can be prepared effectively.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0038664 | 2011-04-25 | ||
KR20110038664 | 2011-04-25 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012148148A2 WO2012148148A2 (en) | 2012-11-01 |
WO2012148148A3 true WO2012148148A3 (en) | 2013-01-03 |
WO2012148148A9 WO2012148148A9 (en) | 2013-02-14 |
Family
ID=47072884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/003135 WO2012148148A2 (en) | 2011-04-25 | 2012-04-24 | Novel zinc azide complex and a process for preparing tetrazole derivatives using the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101942064B1 (en) |
WO (1) | WO2012148148A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109761924B (en) * | 2019-02-26 | 2020-09-01 | 安徽美诺华药物化学有限公司 | Improved post-treatment method of valsartan reaction mixed liquid |
CN112079788A (en) * | 2019-06-13 | 2020-12-15 | 安徽美诺华药物化学有限公司 | Preparation method of valsartan |
CN110467604B (en) * | 2019-08-29 | 2020-09-08 | 浙江天宇药业股份有限公司 | Preparation method of losartan |
EP3939967A1 (en) | 2020-07-15 | 2022-01-19 | KRKA, d.d., Novo mesto | A continuous process for the preparation of (s)-methyl n-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-n-pentanoylvalinate in a flow reactor |
CN113501831B (en) * | 2021-07-15 | 2022-11-15 | 西安近代化学研究所 | 5-aminotetrazole zinc complex, and synthesis method and application thereof |
CN116375687A (en) * | 2021-12-22 | 2023-07-04 | 浙江华海药业股份有限公司 | High-purity losartan potassium and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08325248A (en) * | 1995-05-26 | 1996-12-10 | Chugoku Kayaku Kk | New reagent for synthesizing tetrazole compound and production of tetrazole compound using the same |
GB0316546D0 (en) * | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
CN101774975B (en) * | 2009-12-25 | 2012-11-28 | 中国科学院过程工程研究所 | Ionic liquid catalysis ring-closure reaction method |
-
2012
- 2012-04-24 KR KR1020120042543A patent/KR101942064B1/en active IP Right Grant
- 2012-04-24 WO PCT/KR2012/003135 patent/WO2012148148A2/en active Application Filing
Non-Patent Citations (4)
Title |
---|
DAPPORTO, P. ET AL.: "Addition of Small Molecules by Zn(II) and Cu(II) Dinuclear Complexes Obtained by an Amino-Phenolic Ligand. Crystal Structures of the Dinuclear Zinc Complex Assembling Butanolate and Azide Anions", INORG. CHEM., vol. 40, 2001, pages 6186 - 6192, XP055238302, DOI: doi:10.1021/ic0105415 * |
DEMKO, Z. P. ET AL.: "An Expedient Route to the Tetrazole Analogues of alpha-Amino Acids", ORG. LETT., vol. 4, 2002, pages 2525 - 2527, XP002611922, DOI: doi:10.1021/OL020096X * |
DEMKO, Z. P. ET AL.: "Preparation of 5-Substituted 1H-Tetrazoles from Nitriles in Water", J. ORG. CHEM., vol. 66, 2001, pages 7945 - 7960 * |
HIMO, F. ET AL.: "Why Is Tetrazole Formation by Addition of Azide to Organic Nitriles Catalyzed by Zinc(II) Salts", J. AM. CHEM. SOC., vol. 125, 2003, pages 9983 - 9987, XP002611921 * |
Also Published As
Publication number | Publication date |
---|---|
KR101942064B1 (en) | 2019-01-24 |
KR20120120907A (en) | 2012-11-02 |
WO2012148148A9 (en) | 2013-02-14 |
WO2012148148A2 (en) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014014835A8 (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
WO2012106534A3 (en) | Hiv integrase inhibitors | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
EP2677029A3 (en) | Methods for the manufacture of proteolytically processed polypeptides | |
WO2012148148A3 (en) | Novel zinc azide complex and a process for preparing tetrazole derivatives using the same | |
WO2010015657A3 (en) | Alkoxypyrazoles and the process for their preparation | |
WO2010140765A3 (en) | Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same | |
WO2012042534A3 (en) | Preparation of r-sitagliptin and intermediates thereof | |
UA110128C2 (en) | Normal;heading 1;heading 2;heading 3;INDOLECARBOXAMIDES AND BENZIMIDAZOLECARBOXAMIDES AS INSECTICIDES AND ACARICIDES | |
WO2012146980A3 (en) | Preparation of fingolimod and its salts | |
MX2013013465A (en) | Polymorph of rifaximin and process for the preparation thereof. | |
WO2013093931A3 (en) | Novel prodrugs of phenolic drugs | |
IN2014CN04449A (en) | ||
WO2012131707A3 (en) | Crystalline form of bortezomib, preparation method and pharmaceutical composition there f | |
WO2013067531A3 (en) | Methods of using microrna 195 in providing neuroprotection | |
WO2010098583A3 (en) | Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
MX343701B (en) | Process for alkynylating 16-substituted-17-keto steroids. | |
WO2010039885A3 (en) | Crystalline forms of dexlansoprazole | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
MX2013013417A (en) | Fabric cleaning composition comprising hueing agent. | |
WO2012063115A3 (en) | Process for the preparation of rosuvastatin calcium via novel amine intermediate | |
WO2010018441A3 (en) | Process for the preparation of substantially pure telmisartan | |
WO2013092672A3 (en) | Method for recombinant production of labyrinthopeptins and functional derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12777661 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12777661 Country of ref document: EP Kind code of ref document: A2 |